NCT06442748 2026-02-13
LIBRA
Tata Memorial Centre
Phase 3 Recruiting
Clinical Trials
12 trialsNCT07130786 2026-01-27
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Brigham and Women's Hospital
Phase 2 Recruiting
NCT01857934 2025-11-17
Therapy for Children With Advanced Stage Neuroblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT05735717 2025-07-24
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT03048084 2025-02-04
STING
Leiden University Medical Center
Phase 4 Recruiting
NCT05897658 2024-10-23
LeviTaTe Pilot
Hamilton Health Sciences Corporation
Phase 3 Not yet recruiting
NCT03436433 2023-04-13
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
Duke University
Phase 2 Terminated
NCT02334722 2021-12-15
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
University of Florida
Phase 4 Completed
NCT02815410 2016-06-28
Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Seoul National University Hospital
Phase 2 Unknown
NCT00629889 2013-05-22
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Centre Hospitalier Universitaire Vaudois
Phase 2 Completed
NCT00415376 2012-05-18
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
Northwestern University
Phase NA Withdrawn
NCT00571155 2009-08-20
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
University Hospital Tuebingen
Phase 4 Completed